• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Ascletis receives IND approval for its NASH drug

    BIOSPECTRUMASIA

    Ascletis, 3-V Biosciences Announce NASH Strategic License and Series E Financing

    PRESS RELEASE

    Ascletis and 3-V Biosciences Announce NASH-License and Series E Financing

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.